BEIJING – The secret to the China market, said industry stakeholders during the 2013 BIO Convention in China this week, is to look for and fill unmet medical needs. Read More

HONG KONG – Japan’s biotech stocks have fallen from the precipitous heights they reached through the first half of the year, coming down from a bubble that was driven by a combination of a cheap currency, government stimulus, a new health care policy and a Nobel Prize. Read More

HONG KONG – Hospitals in China are using fewer targeted therapies for lung cancer than their Western counterparts, despite China having the world’s highest number of lung cancer patients and Asians being more susceptible to the disease than Westerners, a leading local oncologist has warned. Read More

BEIJING – In its third year, the BIO Convention in China is billed as a gathering aimed at strengthening ties between Western biopharmas and members of the emerging Chinese biopharma market. Read More

• Sinovac Biotech Ltd., of Beijing, said it was selected by the Jiangsu Centers for Disease Control and Prevention to supply the company’s inactivated hepatitis A vaccine, Healive, under the expanded program of immunization in 2014, to the pediatric population in Jiangsu Province. Read More